{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:40:51Z","timestamp":1789724451635,"version":"4.0.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T00:00:00Z","timestamp":1503100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T00:00:00Z","timestamp":1503100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Foundation for the State of S\u00e3o Paulo Research - FAPESP","award":["PostDoc project # 2015\/18684-9"],"award-info":[{"award-number":["PostDoc project # 2015\/18684-9"]}]},{"name":"Foundation for the State of S\u00e3o Paulo Research - FAPESP","award":["Thematic project # 2013\/50181-1"],"award-info":[{"award-number":["Thematic project # 2013\/50181-1"]}]},{"DOI":"10.13039\/501100004809","name":"FINEP","doi-asserted-by":"crossref","award":["Project # 01.10.0758.01"],"award-info":[{"award-number":["Project # 01.10.0758.01"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CNPq-National Institute of Science and Technology-INCT of Nanobiotechnology","award":["Project # 573880\/2008-5"],"award-info":[{"award-number":["Project # 573880\/2008-5"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biophys Rev"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12551-017-0293-3","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T09:52:41Z","timestamp":1503136361000},"page":"761-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Nanomedicine associated with photodynamic therapy for glioblastoma treatment"],"prefix":"10.1007","volume":"9","author":[{"given":"Leonardo B.","family":"de Paula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando L.","family":"Primo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,19]]},"reference":[{"key":"293_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2014.11.008","volume":"6","author":"HM Abdallah","year":"2015","unstructured":"Abdallah HM, Al-Abd AM, El-Dine RS, El-Halawany AM (2015) P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J Adv Res 6:45\u201362","journal-title":"J Adv Res"},{"key":"293_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-014-0517-x","volume":"15","author":"JP Almeida","year":"2015","unstructured":"Almeida JP, Chaichana KL, Rincon-Torroella J, Quinones-Hinojosa A (2015) The value of extent of resection of glioblastomas: clinical evidence and current approach. Curr Neurol Neurosci Rep 15:1\u201313","journal-title":"Curr Neurol Neurosci Rep"},{"key":"293_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nano.2013.09.011","volume":"10","author":"JPM Almeida","year":"2014","unstructured":"Almeida JPM, Figueroa ER, Drezek RA (2014) Gold nanoparticle mediated cancer immunotherapy. Nanomedicine 10:503\u2013514","journal-title":"Nanomedicine"},{"key":"293_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocn.2014.09.003","volume":"22","author":"RJ Atkins","year":"2015","unstructured":"Atkins RJ, Ng W, Stylli SS, Hovens CM, Kaye AH (2015) Repair mechanisms help glioblastoma resist treatment. J Clin Neurosci 22:14\u201320","journal-title":"J Clin Neurosci"},{"key":"293_CR5","doi-asserted-by":"crossref","unstructured":"Bae KH, Chung HJ, Park TG (2011) Nanomaterials for cancer therapy and imaging. Mol Cells 31:295\u2013302","DOI":"10.1007\/s10059-011-0051-5"},{"key":"293_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphotobiol.2012.05.009","volume":"115","author":"GC Bolfarini","year":"2012","unstructured":"Bolfarini GC, Siqueira-Moura MP, Demets GJ, Morais PC, Tedesco AC (2012) In vitro evaluation of combined hyperthermia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma. J Photochem Photobiol B Biol 115:1\u20134","journal-title":"J Photochem Photobiol B Biol"},{"key":"293_CR7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.dyepig.2013.08.018","volume":"100","author":"GC Bolfarini","year":"2014","unstructured":"Bolfarini GC, Siqueira-Moura MP, Demets GJ, Tedesco AC (2014) Preparation, characterization, and in vitro phototoxic effect of zinc phthalocyanine cucurbit [7] uril complex encapsulated into liposomes. Dyes Pigments 100:162\u2013167","journal-title":"Dyes Pigments"},{"key":"293_CR8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1750-3639.2007.00082.x","volume":"17","author":"DJ Brat","year":"2007","unstructured":"Brat DJ, Scheithauer BW, Fuller GN, Tihan T (2007) Newly codified glial neoplasms of the 2007 WHO classification of tumours of the central nervous system: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 17:319\u2013324","journal-title":"Brain Pathol"},{"key":"293_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1572-1000(05)00007-4","volume":"1","author":"AP Castano","year":"2004","unstructured":"Castano AP, Demidova TN, Hamblin MR (2004) Mechanisms in photodynamic therapy: part one\u2014photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 1:279\u2013293","journal-title":"Photodiagn Photodyn Ther"},{"key":"293_CR10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.addr.2008.08.003","volume":"60","author":"DK Chatterjee","year":"2008","unstructured":"Chatterjee DK, Fong LS, Zhang Y (2008) Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 60:1627\u20131637","journal-title":"Adv Drug Deliv Rev"},{"key":"293_CR11","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2147\/IJN.S45429","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen J, Shao R, Zhang XD, Chen C (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. Int J Nanomedicine 8:2677","journal-title":"Int J Nanomedicine"},{"key":"293_CR12","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","volume":"65","author":"AT Collins","year":"2005","unstructured":"Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946\u201310951","journal-title":"Cancer Res"},{"key":"293_CR13","doi-asserted-by":"crossref","unstructured":"Dang L, White DW, Gross S et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739\u2013744","DOI":"10.1038\/nature08617"},{"key":"293_CR14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0100-40422004000100023","volume":"27","author":"AG de Oliveira","year":"2004","unstructured":"de Oliveira AG, Scarpa MV, Correa MA, Cera LFR, Formariz TP (2004) Microemuls\u00f5es: estrutura e aplica\u00e7\u00f5es como sistema de libera\u00e7\u00e3o de f\u00e1rmacos. Qu\u00edmica Nova 27:131\u2013138","journal-title":"Qu\u00edmica Nova"},{"key":"293_CR15","doi-asserted-by":"crossref","first-page":"07B307","DOI":"10.1063\/1.3671775","volume":"111","author":"LB de Paula","year":"2012","unstructured":"de Paula LB, Primo FL, Jardim DR, Morais PC, Tedesco AC (2012) Development, characterization, and in vitro trials of chloroaluminum phthalocyanine-magnetic nanoemulsion to hyperthermia and photodynamic therapies on glioblastoma as a biological model. J Appl Phys 111:07B307","journal-title":"J Appl Phys"},{"key":"293_CR16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejps.2013.03.011","volume":"49","author":"CS de Paula","year":"2013","unstructured":"de Paula CS, Tedesco AC, Primo FL, Vilela JMC, Andrade MS, Mosqueira VCF (2013) Chloroaluminium phthalocyanine polymeric nanoparticles as photosensitisers: photophysical and physicochemical characterisation, release and phototoxicity in vitro. Eur J Pharm Sci 49:371\u2013381","journal-title":"Eur J Pharm Sci"},{"key":"293_CR17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jmmm.2014.10.098","volume":"380","author":"LB de Paula","year":"2015","unstructured":"de Paula LB, Primo FL, Pinto MR, Morais PC, Tedesco AC (2015) Combination of hyperthermia and photodynamic therapy on mesenchymal stem cell line treated with chloroaluminum phthalocyanine magnetic-nanoemulsion. J Magn Magn Mater 380:372\u2013376","journal-title":"J Magn Magn Mater"},{"key":"293_CR18","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.drudis.2014.06.020","volume":"19","author":"LS del Burgo","year":"2014","unstructured":"del Burgo LS, Pedraz J, Orive G (2014) Advanced nanovehicles for cancer management. Drug Discov Today 19:1659\u20131670","journal-title":"Drug Discov Today"},{"key":"293_CR19","first-page":"2164","volume":"51","author":"AJ Ekstrand","year":"1991","unstructured":"Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor \u03b1, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:2164\u20132172","journal-title":"Cancer Res"},{"key":"293_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jfda.2014.01.001","volume":"22","author":"Z Fan","year":"2014","unstructured":"Fan Z, Fu PP, Yu H, Ray PC (2014) Theranostic nanomedicine for cancer detection and treatment. J Food Drug Anal 22:3\u201317","journal-title":"J Food Drug Anal"},{"key":"293_CR21","doi-asserted-by":"crossref","unstructured":"Ficheux H (2009) Photodynamic therapy: principles and therapeutic indications. Ann Pharmaceut Fr 1:32\u201340","DOI":"10.1016\/j.pharma.2008.10.013"},{"key":"293_CR22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1750-3639.2007.00084.x","volume":"17","author":"GN Fuller","year":"2007","unstructured":"Fuller GN, Scheithauer BW (2007) The 2007 revised World Health Organization (WHO) classification of tumours of the central nervous system: newly codified entities. Brain Pathol 17:304\u2013307","journal-title":"Brain Pathol"},{"key":"293_CR23","doi-asserted-by":"crossref","unstructured":"Furnari FB, Fenton T, Bachoo RM et al (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683\u20132710","DOI":"10.1101\/gad.1596707"},{"key":"293_CR24","doi-asserted-by":"publisher","unstructured":"Huang PH, Xu AM, White FM (2009) Oncogenic EGFR signaling networks in glioma. Sci Signal 2:re6. doi: 10.1126\/scisignal.287re6","DOI":"10.1126\/scisignal.287re6"},{"key":"293_CR25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jphotochem.2006.12.013","volume":"188","author":"M Idowu","year":"2007","unstructured":"Idowu M, Nyokong T (2007) Photophysical and photochemical properties of zinc and aluminum phthalocyanines in the presence of magnetic fluid. J Photochem Photobiol A Chem 188:200\u2013206","journal-title":"J Photochem Photobiol A Chem"},{"key":"293_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2008.04.016","volume":"130","author":"L Jabr-Milane","year":"2008","unstructured":"Jabr-Milane L, van Vlerken L, Devalapally H, Shenoy D, Komareddy S, Bhavsar M, Amiji M (2008) Multi-functional nanocarriers for targeted delivery of drugs and genes. J Control Release 130:121\u2013128","journal-title":"J Control Release"},{"key":"293_CR27","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1073\/pnas.86.8.2858","volume":"86","author":"CD James","year":"1989","unstructured":"James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86:2858\u20132862","journal-title":"Proc Natl Acad Sci USA"},{"key":"293_CR28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1474-4422(10)70105-8","volume":"9","author":"M Jansen","year":"2010","unstructured":"Jansen M, Yip S, Louis DN (2010) Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. Lancet Neurol 9:717\u2013726","journal-title":"Lancet Neurol"},{"key":"293_CR29","doi-asserted-by":"crossref","unstructured":"Jiguet Jiglaire C, Baeza-Kallee N, Denicola\u00ef E et al (2014) Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening. Exp Cell Res 321:99\u2013108","DOI":"10.1016\/j.yexcr.2013.12.010"},{"key":"293_CR30","doi-asserted-by":"crossref","unstructured":"Kanu OO, Hughes B, Di C, Lin N, Fu J, Bigner DD, Yan H et al (2009) Glioblastoma multiforme oncogenomics and signaling pathways. Clin Med Oncol 3:39\u201352","DOI":"10.4137\/CMO.S1008"},{"key":"293_CR31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/ijms11020562","volume":"11","author":"A Karioti","year":"2010","unstructured":"Karioti A, Bilia AR (2010) Hypericins as potential leads for new therapeutics. Int J Mol Sci 11:562\u2013594","journal-title":"Int J Mol Sci"},{"key":"293_CR32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1010684921099","volume":"51","author":"B Kaup","year":"2001","unstructured":"Kaup B, Schindler I, Kn\u00fcpfer H, Schlenzka A, Prei\u03b2 R, Kn\u00fcpfer M (2001) Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J Neuro-Oncol 51:105\u2013110","journal-title":"J Neuro-Oncol"},{"key":"293_CR33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00277-004-0918-z","volume":"83","author":"JW Kim","year":"2004","unstructured":"Kim JW, Kim SY, Park SY, Kim YM, Kim JM, Lee MH, Ryu HM (2004) Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol 83:733\u2013738","journal-title":"Ann Hematol"},{"key":"293_CR34","unstructured":"Kleihues P, Webster K, Cavenee WK (2000) Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer Press, Lyon"},{"key":"293_CR35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1011-1344(01)00267-6","volume":"66","author":"YN Konan","year":"2002","unstructured":"Konan YN, Gurny R, All\u00e9mann E (2002) State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B Biol 66:89\u2013106","journal-title":"J Photochem Photobiol B Biol"},{"key":"293_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1476-4598-9-135","volume":"9","author":"C Krakstad","year":"2010","unstructured":"Krakstad C, Chekenya M (2010) Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 9:135","journal-title":"Mol Cancer"},{"key":"293_CR37","doi-asserted-by":"crossref","unstructured":"Krasnici S, Werner A, Eichhorn ME et al (2003) Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer 105:561\u2013567","DOI":"10.1002\/ijc.11108"},{"key":"293_CR38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1055\/s-2005-861048","volume":"84","author":"A K\u00fcbler","year":"2005","unstructured":"K\u00fcbler A, Niziol C, Sidhu M, D\u00fcnne A, Werner J (2005) Analysis of cost effectiveness of photodynamic therapy with Foscan (Foscan-PDT) in comparison with palliative chemotherapy in patients with advanced head-neck tumors in Germany. Laryngo-Rhino-Otologie 84:725\u2013732","journal-title":"Laryngo-Rhino-Otologie"},{"key":"293_CR39","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1117\/1.2904580","volume":"13","author":"JR Lakowicz","year":"2008","unstructured":"Lakowicz JR, Masters BR (2008) Principles of fluorescence spectroscopy. J Biomed Opt 13:9901","journal-title":"J Biomed Opt"},{"key":"293_CR40","doi-asserted-by":"crossref","unstructured":"Libermann TA, Nusbaum HR, Razon N et al (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144\u2013147","DOI":"10.1038\/313144a0"},{"key":"293_CR41","doi-asserted-by":"crossref","unstructured":"Lim CK, Heo J, Shin S et al (2013) Nanophotosensitizers toward advanced photodynamic therapy of cancer. Cancer Lett 334:176\u2013187","DOI":"10.1016\/j.canlet.2012.09.012"},{"key":"293_CR42","doi-asserted-by":"crossref","unstructured":"Lin L, Xiong L, Wen Y et al (2015) Active targeting of nano-photosensitizer delivery systems for photodynamic therapy of cancer stem cells. J Biomed Nanotechnol 11:531\u2013554","DOI":"10.1166\/jbn.2015.2090"},{"key":"293_CR43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/cmdc.200800042","volume":"3","author":"PC Lo","year":"2008","unstructured":"Lo PC, Fong WP, Ng DK (2008) Effects of peripheral chloro substitution on the photophysical properties and in vitro photodynamic activities of galactose-conjugated silicon (IV) phthalocyanines. ChemMedChem 3:1110\u20131117","journal-title":"ChemMedChem"},{"key":"293_CR44","doi-asserted-by":"crossref","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109","DOI":"10.1007\/s00401-007-0243-4"},{"key":"293_CR45","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1021\/cr5004198","volume":"115","author":"SS Lucky","year":"2015","unstructured":"Lucky SS, Soo KC, Zhang Y (2015) Nanoparticles in photodynamic therapy. Chem Rev 115:1990\u20132042","journal-title":"Chem Rev"},{"key":"293_CR46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jmmm.2005.02.022","volume":"293","author":"PP Macaroff","year":"2005","unstructured":"Macaroff PP, Oliveira DM, Ribeiro KF, Lacava ZG, Lima EC, Morais PC, Tedesco AC (2005) Studies of cell toxicity of complexes of magnetic fluids and biological macromolecules. J Magn Magn Mater 293:293\u2013297","journal-title":"J Magn Magn Mater"},{"key":"293_CR47","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1101\/gad.891601","volume":"15","author":"EA Maher","year":"2001","unstructured":"Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311\u20131333","journal-title":"Genes Dev"},{"key":"293_CR48","unstructured":"McLendon R, Friedman A, Bigner D, et al (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061\u20131068"},{"key":"293_CR49","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa051918","volume":"353","author":"IK Mellinghoff","year":"2005","unstructured":"Mellinghoff IK et al (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353:2012\u20132024","journal-title":"N Engl J Med"},{"key":"293_CR50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10143-003-0267-8","volume":"26","author":"A Merlo","year":"2003","unstructured":"Merlo A (2003) Genes and pathways driving glioblastomas in humans and murine disease models. Neurosurg Rev 26:145\u2013158","journal-title":"Neurosurg Rev"},{"key":"293_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40137-014-0076-8","volume":"3","author":"S Missios","year":"2015","unstructured":"Missios S, Abbassy M, Vogelbaum MA, Recinos PF (2015) Use of image fluorescence in the resection of gliomas. Current Surgery Reports 3:1\u20136","journal-title":"Current Surgery Reports"},{"key":"293_CR52","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.molstruc.2006.12.019","volume":"834","author":"A Molnar","year":"2007","unstructured":"Molnar A, D\u011bdic R, Svoboda A, Hala J (2007) Singlet oxygen production by lipophilic photosensitizers in liposomes studied by time and spectral resolved phosphorescence. J Mol Struct 834:488\u2013491","journal-title":"J Mol Struct"},{"key":"293_CR53","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2147\/IJN.S57420","volume":"9","author":"LA Muehlmann","year":"2014","unstructured":"Muehlmann LA, Ma BC, Longo JPF, Santos MFMA, Azevedo RB (2014) Aluminum\u2013phthalocyanine chloride associated to poly (methyl vinyl ether-co-maleic anhydride) nanoparticles as a new third-generation photosensitizer for anticancer photodynamic therapy. Int J Nanomed 9:1199","journal-title":"Int J Nanomed"},{"key":"293_CR54","first-page":"473","volume":"36","author":"Y Nakazato","year":"2008","unstructured":"Nakazato Y (2008) The 4th edition of WHO classification of tumours of the central nervous system published in 2007 no shinkei geka. Neurol Surg 36:473","journal-title":"Neurol Surg"},{"key":"293_CR55","doi-asserted-by":"crossref","unstructured":"Natsume A, Wakabayashi T, Ishii D et al (2008) A combination of IFN-\u03b2 and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation. Cancer Chemother Pharmacol 61:653\u2013659","DOI":"10.1007\/s00280-007-0520-x"},{"key":"293_CR56","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1158\/1078-0432.CCR-06-0874","volume":"12","author":"MK Nicholas","year":"2006","unstructured":"Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R (2006) Epidermal growth factor receptor\u2013mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res 12:7261\u20137270","journal-title":"Clin Cancer Res"},{"key":"293_CR57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.addr.2009.01.004","volume":"61","author":"N Nishiyama","year":"2009","unstructured":"Nishiyama N, Morimoto Y, Jang W-D, Kataoka K (2009) Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev 61:327\u2013338","journal-title":"Adv Drug Deliv Rev"},{"key":"293_CR58","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0891-5849(03)00026-1","volume":"34","author":"M Niziolek","year":"2003","unstructured":"Niziolek M, Korytowski W, Girotti AW (2003) Nitric oxide inhibition of free radical-mediated lipid peroxidation in photodynamically treated membranes and cells. Free Radic Biol Med 34:997\u20131005","journal-title":"Free Radic Biol Med"},{"key":"293_CR59","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/0040-4039(95)00493-V","volume":"36","author":"S Nonell","year":"1995","unstructured":"Nonell S, Bou N, Borrell J, Teixid\u00f3 J, Villanueva A, Juarranz A, Ca\u00f1ete M (1995) Synthesis of 2, 7, 12, 17-tetraphenylporphycene (TPPo). First aryl-substituted porphycene for the photodynamic therapy of tumors. Tetrahedron Lett 36:3405\u20133408","journal-title":"Tetrahedron Lett"},{"key":"293_CR60","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/adfm.200801127","volume":"19","author":"JM Oh","year":"2009","unstructured":"Oh JM, Choi SJ, Lee GE, Han SH, Choy JH (2009) Inorganic drug delivery nanovehicle conjugated with cancer cell-specific ligand. Adv Funct Mater 19:1617\u20131624","journal-title":"Adv Funct Mater"},{"key":"293_CR61","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","volume":"170","author":"H Ohgaki","year":"2007","unstructured":"Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445\u20131453","journal-title":"Am J Pathol"},{"key":"293_CR62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/ma6030817","volume":"6","author":"AB Ormond","year":"2013","unstructured":"Ormond AB, Freeman HS (2013) Dye sensitizers for photodynamic therapy. Materials 6:817\u2013840","journal-title":"Materials"},{"key":"293_CR63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biocel.2014.06.007","volume":"53","author":"E Pastwa","year":"2014","unstructured":"Pastwa E, Poplawski T, Lewandowska U, Somiari SB, Blasiak J, Somiari RI (2014) Wortmannin potentiates the combined effect of etoposide and cisplatin in human glioma cells. Int J Biochem Cell Biol 53:423\u2013431","journal-title":"Int J Biochem Cell Biol"},{"key":"293_CR64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/5289","volume":"17","author":"A Persidis","year":"1999","unstructured":"Persidis A (1999) Cancer multidrug resistance. Nat Biotechnol 17:94\u201395","journal-title":"Nat Biotechnol"},{"key":"293_CR65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1078\/1615-1615-00082","volume":"18","author":"K Plaetzer","year":"2003","unstructured":"Plaetzer K, Kiesslich T, Verwanger T, Krammer B (2003) The modes of cell death induced by PDT: an overview. Medical Laser Application 18:7\u201319","journal-title":"Medical Laser Application"},{"key":"293_CR66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0733-8619(05)70256-5","volume":"14","author":"S Preston-Martin","year":"1996","unstructured":"Preston-Martin S (1996) Epidemiology of primary CNS neoplasms. Neurol Clin 14:273\u2013290","journal-title":"Neurol Clin"},{"key":"293_CR67","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1166\/jnn.2008.18137","volume":"8","author":"FL Primo","year":"2008","unstructured":"Primo FL, Bentley MV, Tedesco AC (2008) Photophysical studies and in vitro skin permeation\/retention of Foscan\u00ae\/nanoemulsion (NE) applicable to photodynamic therapy skin cancer treatment. J Nanosci Nanotechnol 8:340\u2013347","journal-title":"J Nanosci Nanotechnol"},{"key":"293_CR68","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.2174\/092986712803530502","volume":"19","author":"FL Primo","year":"2012","unstructured":"Primo FL, De Paula LB, de Siqueira-Moura MP, Tedesco AC (2012) Photobiostimulation on wound healing treatment by ClAlPc-nanoemulsion from a multiple-wavelength portable light source on a 3D-human stem cell dermal equivalent. Curr Med Chem 19:5157\u20135163","journal-title":"Curr Med Chem"},{"key":"293_CR69","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.5858\/133.7.1062","volume":"133","author":"P Pytel","year":"2009","unstructured":"Pytel P, Lukas RV (2009) Update on diagnostic practice: tumors of the nervous system. Archives of Pathology & Laboratory Medicine 133:1062\u20131077","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"293_CR70","unstructured":"Rao RD, James CD (2004) Altered molecular pathways in gliomas: an overview of clinically relevant issues. In: Seminars in Oncology, vol 5. Elsevier, New York Amsterdam, pp 595\u2013604"},{"key":"293_CR71","doi-asserted-by":"crossref","unstructured":"Ren Y, Wang R, Liu Y et al (2014) A hematoporphyrin-based delivery system for drug resistance reversal and tumor ablation. Biomaterials 35:2462\u20132470","DOI":"10.1016\/j.biomaterials.2013.12.004"},{"key":"293_CR72","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molonc.2009.05.001","volume":"3","author":"VP Ret\u00e8l","year":"2009","unstructured":"Ret\u00e8l VP, Hummel MJ, van Harten WH (2009) Review on early technology assessments of nanotechnologies in oncology. Mol Oncol 3:394\u2013401","journal-title":"Mol Oncol"},{"key":"293_CR73","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1751-1097.1991.tb09900.x","volume":"53","author":"I Rosenthal","year":"1991","unstructured":"Rosenthal I (1991) Phthalocyanines as photodynamic sensitizers. Photochem Photobiol 53:859\u2013870","journal-title":"Photochem Photobiol"},{"key":"293_CR74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/09553009514550111","volume":"67","author":"I Rosenthal","year":"1995","unstructured":"Rosenthal I, Ben-Hur E (1995) Role of oxygen in the phototoxicity of phthalocyanines. Int J Radiat Biol 67:85\u201391","journal-title":"Int J Radiat Biol"},{"key":"293_CR75","doi-asserted-by":"crossref","unstructured":"Rubenstein J, Rakic P (eds) (2013) Cellular migration and formation of neuronal connections. Comprehensive developmental neuroscience, vol 2. Academic Press, New York vol 2","DOI":"10.1016\/B978-0-12-397266-8.09995-6"},{"key":"293_CR76","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cmdc.201300449","volume":"9","author":"R Saavedra","year":"2014","unstructured":"Saavedra R, Rocha LB, D\u0105browski JM, Arnaut LG (2014) Modulation of biodistribution, pharmacokinetics, and photosensitivity with the delivery vehicle of a bacteriochlorin photosensitizer for photodynamic therapy. ChemMedChem 9:390\u2013398","journal-title":"ChemMedChem"},{"key":"293_CR77","doi-asserted-by":"crossref","unstructured":"Sadzuka Y, Iwasaki F, Sugiyama I et al (2008) Phototoxicity of coproporphyrin as a novel photodynamic therapy was enhanced by liposomalization. Toxicol Lett 182:110\u2013114","DOI":"10.1016\/j.toxlet.2008.09.002"},{"key":"293_CR78","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1359-6446(99)01412-9","volume":"4","author":"WM Sharman","year":"1999","unstructured":"Sharman WM, Allen CM, Van Lier JE (1999) Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today 4:507\u2013517","journal-title":"Drug Discov Today"},{"key":"293_CR79","doi-asserted-by":"crossref","unstructured":"Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396\u2013401","DOI":"10.1038\/nature03128"},{"key":"293_CR80","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.msec.2012.12.088","volume":"33","author":"MP Siqueira-Moura","year":"2013","unstructured":"Siqueira-Moura MP, Primo FL, Espreafico EM, Tedesco AC (2013) Development, characterization, and photocytotoxicity assessment on human melanoma of chloroaluminum phthalocyanine nanocapsules. Mater Sci Eng C 33:1744\u20131752","journal-title":"Mater Sci Eng C"},{"key":"293_CR81","first-page":"9","volume":"65","author":"MP Siqueira-Moura","year":"2010","unstructured":"Siqueira-Moura MP, Primo FL, Peti APF, Tedesco AC (2010) Validated spectrophotometric and spectrofluorimetric methods for determination of chloroaluminum phthalocyanine in nanocarriers. Pharmazie 65:9\u201314","journal-title":"Pharmazie"},{"key":"293_CR82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pdpdt.2009.12.005","volume":"7","author":"B Somani","year":"2010","unstructured":"Somani B, Moseley H, Eljamel M, Nabi G, Kata S (2010) Photodynamic diagnosis (PDD) for upper urinary tract transitional cell carcinoma (UT-TCC): evolution of a new technique. Photodiagn Photodyn Ther 7:39\u201343","journal-title":"Photodiagn Photodyn Ther"},{"key":"293_CR83","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coche.2014.12.003","volume":"7","author":"DS Spencer","year":"2015","unstructured":"Spencer DS, Puranik AS, Peppas NA (2015) Intelligent nanoparticles for advanced drug delivery in cancer treatment. Curr Opin Chem Eng 7:84\u201392","journal-title":"Curr Opin Chem Eng"},{"key":"293_CR84","doi-asserted-by":"crossref","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","DOI":"10.1056\/NEJMoa043330"},{"key":"293_CR85","doi-asserted-by":"crossref","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466","DOI":"10.1016\/S1470-2045(09)70025-7"},{"key":"293_CR86","unstructured":"Tada DB (2007) Desenvolvimento de nanopart\u00edculas fotossensibilizadoras. Universidade de S\u00e3o Paulo, S\u00e3o Paulo"},{"key":"293_CR87","doi-asserted-by":"crossref","unstructured":"Tapaj\u00f3s EC, Longo JP, Simioni AR et al (2008) In vitro photodynamic therapy on human oral keratinocytes using chloroaluminum-phthalocyanine. Oral Oncol 44:1073\u20131079","DOI":"10.1016\/j.oraloncology.2008.01.013"},{"key":"293_CR88","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","volume":"4","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145\u2013160","journal-title":"Nat Rev Drug Discov"},{"key":"293_CR89","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jocn.2009.09.004","volume":"17","author":"B Tran","year":"2010","unstructured":"Tran B, Rosenthal M (2010) Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci 17:417\u2013421","journal-title":"J Clin Neurosci"},{"key":"293_CR90","doi-asserted-by":"crossref","unstructured":"Trylcova J, Busek P, Smetana Jr K, Balaziova E, Dvorankova B, Mifkova A, Sedo A (2015) Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro. Tumor Biol 36(8):5873\u20135879","DOI":"10.1007\/s13277-015-3259-8"},{"key":"293_CR91","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3322\/caac.20069","volume":"60","author":"EG Van Meir","year":"2010","unstructured":"Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166\u2013193","journal-title":"CA Cancer J Clin"},{"key":"293_CR92","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijrobp.2010.09.019","volume":"82","author":"PR Wachsberger","year":"2012","unstructured":"Wachsberger PR, Lawrence YR, Liu Y, Daroczi B, Xu X, Dicker AP (2012) Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts. Int J Radiat Oncol Biol Phys 82:483\u2013491","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"293_CR93","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1517\/17460441.2011.564158","volume":"6","author":"TT Wager","year":"2011","unstructured":"Wager TT, Villalobos A, Verhoest PR, Hou X, Shaffer CL (2011) Strategies to optimize the brain availability of central nervous system drug candidates. Expert Opin Drug Discovery 6:371\u2013381","journal-title":"Expert Opin Drug Discovery"},{"key":"293_CR94","doi-asserted-by":"crossref","unstructured":"Wong KK, deLeeuw RJ, Dosanjh NS et al (2007) A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 80:91\u2013104","DOI":"10.1086\/510560"},{"key":"293_CR95","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.dyepig.2012.09.014","volume":"96","author":"Y-T Yang","year":"2013","unstructured":"Yang Y-T, Chen C-T, Tsai T (2013) Absorption and fluorescence spectral properties of hematoporphyrin in liposomes, micelles, and nanoparticles. Dyes Pigments 96:763\u2013769","journal-title":"Dyes Pigments"},{"key":"293_CR96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0959-8049(01)00230-1","volume":"37","author":"Y Yarden","year":"2001","unstructured":"Yarden Y (2001) The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities. Eur J Cancer 37:3\u20138","journal-title":"Eur J Cancer"},{"key":"293_CR97","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127\u2013137","journal-title":"Nat Rev Mol Cell Biol"},{"key":"293_CR98","doi-asserted-by":"crossref","unstructured":"Zahonero C, S\u00e1nchez-G\u00f3mez P (2014) EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy. Cell Mol Life Sci:1\u201324","DOI":"10.1007\/s00018-014-1608-1"}],"container-title":["Biophysical Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12551-017-0293-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-017-0293-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-017-0293-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T13:41:54Z","timestamp":1659361314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12551-017-0293-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,19]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1007\/s12551-017-0293-3","relation":{},"ISSN":["1867-2450","1867-2469"],"issn-type":[{"value":"1867-2450","type":"print"},{"value":"1867-2469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,19]]},"assertion":[{"value":"23 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that thhe have no conflicts of interest regarding this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest statement"}},{"value":"This article does not contain any studies with human participants or animals performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval statement"}}]}}